Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Individualized Management With Low Recurrence Rates
Authors:
- Chen-Hsen LeeCLChen-Hsen Lee
- Ling-Ming TsengLTLing-Ming Tseng
- Jui-Yu ChenJCJui-Yu Chen
- Hsin-Yun HsiaoHHHsin-Yun Hsiao
- An-Hang YangAYAn-Hang Yang
- 1 January 2006
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 13 (1) , 103-109
Abstract
To evaluate the outcomes in different surgical modalities for primary hyperparathyroidism in multiple endocrine neoplasia type 1 (MEN1) patients, intraoperative findings from a single surgeon were studied to investigate a potentially improved modality of parathyroidectomy (PTx). All 22 patients had PTx by a single surgeon in the past 21 years. Three modalities of PTx were used, depending on the operative findings, after all parathyroids and the thymus were identified. If fewer than three glands were enlarged, selective removal of the enlarged glands with or without biopsy of a normal-appearing gland was performed (selective PTx); if all glands were enlarged, either a subtotal PTx leaving a 50-mg remnant in situ or a total PTx with autotransplantation (TPTx + AT) was performed. There were 7 men and 15 women, aged 22 to 67 years (average, 43 years). Sixteen had familial and six had sporadic MEN1. They underwent 23 operations, including 11 selective PTx, 6 subtotal PTx, and 6 TPTx + AT. On follow-up for 1 to 19 years, only one patient (4.6%) had recurrent hyperparathyroidism 5.5 years after subtotal PTx. Others had either normocalcemia (n = 14; 63.6%) or hypocalcemia (n = 7; 31.8%). Those who had either a subtotal PTx or TPTx + AT had a significantly higher rate of postoperative hypocalcemia than those who had a selective PTx (9.9% vs. 54.5%; P = .032; Fisher's exact test). Primary hyperparathyroidism in our MEN1 patients was less aggressive than that reported in the literature. Selective PTx according to the intraoperative findings achieved optimal outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Long-term Biochemical Results after Operative Treatment of Primary Hyperparathyroidism Associated with Multiple Endocrine Neoplasia Types I and IIa: Is a More or Less Extended Operation Essential?British Journal of Surgery, 2001
- Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1Human Molecular Genetics, 1997
- Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2ASurgery, 1996
- The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patientJournal of Internal Medicine, 1995
- Findings and long‐term results of parathyroid surgery in multiple endocrine neoplasia type 1World Journal of Surgery, 1992
- Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1Clinical Endocrinology, 1991
- Multiple endocrine syndrome type I. Clinical, laboratory findings, and management in five familiesCancer, 1989
- Parathyroid Mitogenic Activity in Plasma from Patients with Familial Multiple Endocrine Neoplasia Type 1New England Journal of Medicine, 1986
- Long-term Evaluation of Patients with Primary Parathyroid Hyperplasia Managed by Total Parathyroidectomy and Heterotopic AutotransplantationAnnals of Surgery, 1980
- Regulation by Calcium of Parathyroid Growth and Secretion in vitroNature, 1963